Skip to main content
Premium Trial:

Request an Annual Quote

Software Acceleration Firm Mitrionics Raises $6M in VC Financing

NEW YORK (GenomeWeb News) - Software developer Mitrionics has raised $6 million in venture capital financing from a group of Scandinavian capital firms, the company said today.
Mitrionics, based in Lund, Sweden, said it plans to use the cash to develop and fund its field programmable gate array accelerated computing and processing programs, and to expand its sales and R&D efforts.
Investors in the round include Grande Ventures, Creandum, and Teknoinvest.
Mitrionics said its software can accelerate bioinformatics algorithms such as Blast and other applications for use on FPGAs so that they run 20 times or more faster than on traditional processors.

Filed under

The Scan

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.

Machine Learning Improves Diagnostic Accuracy of Breast Cancer MRI, Study Shows

Combining machine learning with radiologists' interpretations further increased the diagnostic accuracy of MRIs for breast cancer, a Science Translational Medicine paper finds.

Genome Damage in Neurons Triggers Alzheimer's-Linked Inflammation

Neurons harboring increased DNA double-strand breaks activate microglia to lead to neuroinflammation like that seen in Alzheimer's disease, a new Science Advances study finds.

Long COVID-19 Susceptibility Clues Contained in Blood Plasma Proteome

A longitudinal study in eBioMedicine found weeks-long blood plasma proteome shifts after SARS-CoV-2 infection, along with proteomic signatures that appeared to coincide with long Covid risk.